Log In
Print
BCIQ
Print
Print this Print this
 

Entereg, alvimopan

Also known as: ADL 8-2698

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionMu opioid receptor (OPRM1; MOR) antagonist
Molecular Target Mu opioid receptor (MOR) (OPRM1)
Mechanism of ActionMu opioid receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPost-operative ileus
Indication DetailsTreat post-operative ileus (POI)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$9,930.0M

$8,621.0M

$209.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today